Clinical Trials Browser

Absorptiometry, Photon × Genitourinary × 90 days × Clear all

NCT04851119 2026-02-24

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Carcinoma, Hepatocellular, Lymphoma, Non-Hodgkin, Melanoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Ewing, Osteosarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Hepatoblastoma, Desmoid Tumors

NCT02776436 2026-02-17

REDEX

Phase 1 Completed

46 enrolled

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT05838716 2026-01-15

ViPER

Phase 3 Recruiting

240 enrolled

Genitourinary

Prostatic Neoplasms

NCT06039371 2026-01-14

Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study

Phase 2 Recruiting

69 enrolled

Genitourinary

Prostatic Neoplasms